

Drug Class: Growth Hormone-Releasing Hormone (GHRH) Analog
Active Substance: Sermorelin
Strength: 5 mg/vial
Form: Lyophilized Powder
Amount: 2 mL Vial
Active Life: 10–20 minutes (biological), longer with injection
Average Dose: 100–300 mcg per administration
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: Mild-indirect via GH/IGF-1 stimulation
Androgenic Rate: None
Manufacturer: Peptide Hubs
Sermorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), designed to stimulate the pituitary gland to increase natural human growth hormone (HGH) production. Peptide Hubs Sermorelin 5 mg is manufactured under strict laboratory protocols, making it ideal for scientific research purposes in the United States.
Sermorelin mimics endogenous GHRH, binding to pituitary receptors and promoting pulsatile release of HGH. This downstream increase in HGH supports the elevation of IGF-1, a hormone tied to muscle growth, cellular repair, and fat metabolism. Unlike direct HGH administration, Sermorelin stimulates the body's own axis, which may help preserve feedback sensitivity.
Common investigational doses of Sermorelin range from 100 to 300 mcg per injection, typically administered subcutaneously once daily before bed to mimic natural GH release patterns.
For additional details on the mechanism and benefits of Sermorelin in clinical settings, see this NIH review on GHRH analogs like Sermorelin.
Looking to conduct your research with high-purity Sermorelin? This vendor offers reliable Sermorelin supply and lab-backed formulations for consistent results.
Peptide Hubs peptides are lab-tested for identity, purity, and endotoxin levels. Their Sermorelin peptide is no exception—delivered as a lyophilized powder to preserve stability during transit and storage.
Sermorelin is primarily studied as a growth hormone-releasing hormone analog to stimulate natural HGH production in test models.
It is typically injected subcutaneously, often before sleep, in microgram-range doses such as 100–300 mcg per administration.
No, Sermorelin is neither anabolic nor androgenic. It indirectly supports tissue repair by increasing endogenous HGH and IGF-1 levels.
No. Sermorelin is not metabolized by the liver and carries no known hepatotoxicity risks in research settings.
Please log in to write Sermorelin 5 mg review.
Drug Class: Growth Hormone Releasing Hormone (GHRH) Analog
Active Substance: Sermorelin
Strength: 5 mg/vial
Form: Lyophilized Powder
Amount: 2 mL Vial
Active Life: ~10–12 minutes (biological activity extends longer)
Average Dose: 100–300 mcg 1–2x daily
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: Indirect via GH stimulation
Androgenic Rate: None
Manufacturer: Dragon Pharma
Drug Class: Peptide Hormone (Gonadotropin)
Active Substance: Human Chorionic Gonadotropin (HCG)
Strength: 2500 IU/vial
Form: Lyophilized Powder
Amount: 2 mL Vial
Active Life: 64–72 hours
Average Dose: 250–1000 IU 2–3x/week (PCT); 500–2000 IU/week (on-cycle support)
Liver Toxicity: None
Aromatization Rate: Indirectly increases estrogen via testosterone conversion
Anabolic Rate: None (supports natural testosterone production)
Androgenic Rate: Low (via LH stimulation)
Manufacturer: Dragon Pharma
Laboratory Test: View Result